Does DACOMITINIB Cause Off label use? 35 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 35 reports of Off label use have been filed in association with DACOMITINIB (Vizimpro). This represents 5.1% of all adverse event reports for DACOMITINIB.
35
Reports of Off label use with DACOMITINIB
5.1%
of all DACOMITINIB reports
10
Deaths
10
Hospitalizations
How Dangerous Is Off label use From DACOMITINIB?
Of the 35 reports, 10 (28.6%) resulted in death, 10 (28.6%) required hospitalization.
Is Off label use Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for DACOMITINIB. However, 35 reports have been filed with the FAERS database.
What Other Side Effects Does DACOMITINIB Cause?
Death (253)
Diarrhoea (114)
Rash (108)
Neoplasm progression (78)
Paronychia (55)
Blood pressure increased (47)
Pruritus (34)
Dyspnoea (30)
Carcinoembryonic antigen increased (28)
Pain (28)
What Other Drugs Cause Off label use?
RITUXIMAB (39,751)
INFLIXIMAB (34,801)
DENOSUMAB (34,612)
METHOTREXATE (24,020)
VEDOLIZUMAB (21,017)
ETANERCEPT (20,178)
TOCILIZUMAB (18,256)
PREDNISONE (17,867)
LENALIDOMIDE (17,017)
ADALIMUMAB (16,417)
Which DACOMITINIB Alternatives Have Lower Off label use Risk?
DACOMITINIB vs DACTINOMYCIN
DACOMITINIB vs DALBAVANCIN
DACOMITINIB vs DALFAMPRIDINE
DACOMITINIB vs DALTEPARIN
DACOMITINIB vs DAMOCTOCOG ALFA PEGOL